Wednesday, September 13, 2006
Reuters: Pfizer Inc said on Sept. 13 a court in the Netherlands ruled that the basic patent covering atorvastatin -- the active ingredient in Pfizer's cholesterol drug Lipitor -- would be infringed by a competitor product from generics manufacturer Ranbaxy Laboratories Ltd.
0 Comments:
Post a Comment
<< Home